{"filing":{"accession_number":"0001034842-26-000041","cik":"0001034842","ticker":"RIGL","company_name":"RIGEL PHARMACEUTICALS INC","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"rigl-20260514.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1034842/000103484226000041/rigl-20260514.htm"},"events":[{"id":9702,"run_id":8502,"accession_number":"0001034842-26-000041","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Rigel Pharmaceuticals held its Annual Meeting of Stockholders on May 20, 2026, with stockholders voting on five matters: election of three directors (Alison Hannah, Walter Moos, and Raul Rodriguez), approval of amendments to the 2018 Equity Incentive Plan (adding 500,000 shares) and the 2000 Employee Stock Purchase Plan (adding 360,000 shares), a say-on-pay advisory vote, and ratification of Ernst \u0026 Young as auditor. All matters passed with substantial majorities.","company_name":"RIGEL PHARMACEUTICALS INC","ticker":"RIGL","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":472,"accession_number":"0001034842-26-000041","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses stockholder approval of amendments to two equity compensation plans: the 2018 Equity Incentive Plan (adding 500,000 shares) and the 2000 Employee Stock Purchase Plan (adding 360,000 shares). These amendments directly affect the compensatory arrangements available to directors and officers under the Company's equity plans, which is the core subject matter of Item 5.02(e). The material increase in authorized shares for equity issuance would affect investor assessment of potential dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:40:34.512865+00:00","company_name":"","ticker":null,"filing_date":""},{"id":473,"accession_number":"0001034842-26-000041","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Stockholders. The filing presents voting tallies for five matters: election of three directors (Alison Hannah, Walter Moos, and Raul Rodriguez), approval of the Amended 2018 Equity Incentive Plan, approval of the Amended 2000 Employee Stock Purchase Plan, say-on-pay advisory vote, and ratification of Ernst \u0026 Young as auditor. All matters passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and compensation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:40:34.512865+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":472,"accession_number":"0001034842-26-000041","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses stockholder approval of amendments to two equity compensation plans: the 2018 Equity Incentive Plan (adding 500,000 shares) and the 2000 Employee Stock Purchase Plan (adding 360,000 shares). These amendments directly affect the compensatory arrangements available to directors and officers under the Company's equity plans, which is the core subject matter of Item 5.02(e). The material increase in authorized shares for equity issuance would affect investor assessment of potential dilution and executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:40:34.512865+00:00","company_name":"RIGEL PHARMACEUTICALS INC","ticker":"RIGL","filing_date":"2026-05-20"},{"id":473,"accession_number":"0001034842-26-000041","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Stockholders. The filing presents voting tallies for five matters: election of three directors (Alison Hannah, Walter Moos, and Raul Rodriguez), approval of the Amended 2018 Equity Incentive Plan, approval of the Amended 2000 Employee Stock Purchase Plan, say-on-pay advisory vote, and ratification of Ernst \u0026 Young as auditor. All matters passed with substantial majorities. Shareholder vote results are material to investors as they confirm governance and compensation decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:40:34.512865+00:00","company_name":"RIGEL PHARMACEUTICALS INC","ticker":"RIGL","filing_date":"2026-05-20"}]}